Skip to main content
. 2014 Oct 28;2014(10):CD007482. doi: 10.1002/14651858.CD007482.pub3

Morrison 1973.

Methods Quasi‐RCT; 2 parallel groups.
Unit of randomization: individual.
Participants Dates of data collection: not reported.
Setting: City of Memphis Hospitals, Tennessee; indigent women, many obstetric and metabolic complications.
Inclusion criteria: all women undergoing CS. N = 330.
Exclusion criteria: febrile or infected.
Interventions Intervention: drug combination [penicillin + aminoglycoside]:
  • aqueous penicillin 10 MU every 8 hrs and kanamycin 500 mg IM every 12 hrs pre‐operatively and for 3 days post‐operatively;

  • N = 115.


Comparison: no treatment:
  • no treatment;

  • N = 115.

Outcomes Fever (> 100.9oF after 2nd post‐operative day), severe pelvic infection (treatment 27% vs control 7%); 'free of infectious morbidity' (3.6 vs 6.8 days); maternal hospital stay (5.4 vs 8.8 days, no variance given).
Notes No adverse drug reactions reported; no evidence of development of resistance reported.
 Unable to ascertain from description of study incidence of endometritis or wound infection; inadequate description of nature of severe pelvic infections (not included as outcome in analysis).
 2 groups of women were studied retrospectively (N = 75); methods nor results do not specifically describe results of this group and it is unclear whether they have been included in the overall results.
Class of antibiotic: aminoglycoside‐containing combination (natural penicillin and aminoglycoside.
Subgroups:
  • type of CS unclear;

  • before cord clamping.


The 2 groups were comparable regarding gravidity, parity, age and operative indicators.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) High risk Quote: "...every other patient".
Comment: quasi‐RCT. Alternate allocation to treatment or no treatment.
Allocation concealment (selection bias) Unclear risk Comment: no information provided.
Incomplete outcome data (attrition bias) 
 All outcomes Low risk Comment: no loss to follow‐up; no participants excluded. ITT analysis.
Selective reporting (reporting bias) Unclear risk Comment: insufficient information to judge.
Blinding of participants and personnel (performance bias) 
 All outcomes High risk Comment: no blinding; not placebo‐controlled.
Blinding of outcome assessment (detection bias) 
 All outcomes High risk Comment: probably outcome assessment was not blinded.
Other bias Low risk Comment: no other sources of bias identified.